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ARTICLE OPEN
Exploring the variation in implementation of a COPD disease
management programme and its impact on health outcomes:
a post hoc analysis of the RECODE cluster randomised trial
Melinde RS Boland1,2, Annemarije L Kruis3, Simone A Huygens1,2, Apostolos Tsiachristas1,2,4, Willem JJ Assendelft5, Jacobijn Gussekloo3,
Coert MG Blom6, Niels H Chavannes3 and Maureen PMH Rutten-van Mölken1,2
This study aims to (1) examine the variation in implementation of a 2-year chronic obstructive pulmonary disease (COPD)
management programme called RECODE, (2) analyse the facilitators and barriers to implementation and (3) investigate the
inﬂuence of this variation on health outcomes. Implementation variation among the 20 primary-care teams was measured
directly using a self-developed scale and indirectly through the level of care integration as measured with the Patient Assessment
of Chronic Illness Care (PACIC) and the Assessment of Chronic Illness Care (ACIC). Interviews were held to obtain detailed
information regarding the facilitators and barriers to implementation. Multilevel models were used to investigate the association
between variation in implementation and change in outcomes. The teams implemented, on average, eight of the 19 interventions,
and the speciﬁc package of interventions varied widely. Important barriers and facilitators of implementation were (in)sufﬁcient
motivation of healthcare provider and patient, the high starting level of COPD care, the small size of the COPD population per team,
the mild COPD population, practicalities of the information and communication technology (ICT) system, and hurdles in
reimbursement. Level of implementation as measured with our own scale and the ACIC was not associated with health outcomes. A
higher level of implementation measured with the PACIC was positively associated with improved self-management capabilities,
but this association was not found for other outcomes. There was a wide variety in the implementation of RECODE, associated with
barriers at individual, social, organisational and societal level. There was little association between extent of implementation and
health outcomes.
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INTRODUCTION
Integrated Disease Management (DM) is a popular approach for
improving the quality and efﬁciency of care in chronic obstructive
pulmonary disease (COPD) patients. However, the key elements
of DM programmes for COPD (herein, COPD-DM) are not yet
fully understood.1–3 The cost-effectiveness of these programmes
varies considerably,4 most likely depending on the duration,
target population and components of the intervention.5,6
Moreover, wide variation exists, even in the implementation of a
single programme.7,8 This variation can be due to adjustments
for the local setting, or due to differences in speciﬁc barriers
and facilitators that inﬂuence implementation.9,10 Therefore, it is
important to understand the conditions needed for the successful
implementation of a DM programme.11
We aimed to (i) examine the variation in implementation
of a single COPD-DM programme (RECODE) between different
primary-care teams, (ii) analyse the facilitators of and barriers
to implementation and (iii) investigate the association
between the extent of implementation and health outcomes.
This study was performed as a pre-speciﬁed part of the RECODE
trial.12
RESULTS
Table 1 summarises the characteristics of the teams and their
COPD patients. Each team enrolled 11–55 patients and 53 percent
of the teams were delivering ad hoc reactive care.
The telephone interviews were held with ﬁve general practi-
tioners (GPs) and 17 practice nurses from 17 of the 20 (85%)
teams. These interviews varied in length between 20 and 45min.
Three (15%) teams could not be interviewed because the
participating caregiver(s) had left or changed practice or because
the caregiver(s) lacked time. The response rate of the ques-
tionnaires can be found in Appendix 2.
Implementation
The teams implemented, on average, 8 of the 19 interventions
(range: 2–14, Table 2). The most frequently applied interventions
were cooperation with physiotherapist(s) (88%), exacerbation
management (76%) and active identiﬁcation and monitoring of
high-risk COPD patients (71%). Only a few teams improved
cooperation with lung specialist(s) (18%), substituted care from
secondary to primary care (24%), actively applied motivational
interviewing to improve self-management (18%) and used
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additional funding for physiotherapy (12%). In the second study
year, none of the teams used the ITC system 'Zorgdraad'. Teams
with a lower starting level implemented, on average, more
interventions than did teams with a higher starting level.
The total Patient Assessment of Chronic Illness Care (PACIC)
score did not signiﬁcantly change over the study period (Table 3).
However, the PACIC component ‘decision support’ signiﬁcantly
decreased. Even though the total Assessment of Chronic Illness
Care (ACIC) score did not signiﬁcantly change, the ACIC
components ‘organisation of healthcare system’, ‘community
linkages’ and ‘self-management’ signiﬁcantly improved over the
ﬁrst year.
Barriers and facilitators
Table 4 summarises the barriers and facilitators to implementation
as they were perceived by the teams grouped into individual,
social, organisational and broader societal factors. These groups
were not mutually exclusive.
Individual factors
Caregivers were positive about the RECODE course, stating
that it was informative, increased attention to COPD, and inspired
and motivated them to improve COPD care. For instance, 13
teams reported a greater awareness of early recognition of
exacerbations, and many teams implemented symptom-reporting
policies to increase early treatment of exacerbations. Teams
also ﬁne-tuned self-management, which was already (partly)
integrated. For instance, most teams were familiar with
motivational interviewing and individual treatment plans, but
not every plan was put in writing or was made in consultation
with the patient.
A barrier to implementation was the lack of motivation of
patients. Several teams reported difﬁculties in persuading COPD
patients to adopt healthier behaviour because they did not feel ill
or did not experience (many) problems. Furthermore, because of
the lack of patients’ motivation, familiarity with computers and
obligation to use web-based applications, few patients used
Zorgdraad. The lack of motivation or time to determine how
Zorgdraad worked was also an important barrier among
caregivers in using Zorgdraad.
Social factors
During the refresher courses, the teams discussed their
implementation experiences with other teams. That way they
motivated, inspired and learnt from each other. These
presentations were generally appreciated, although some were
dissatisﬁed that presenters had begun implementation rather late,
as a result of which they had little experience to share.
The professional network in which the teams operated was also
a barrier to implementation. For instance, inconsistent use of
Zorgdraad among team members jeopardised the potential
contribution of Zorgdraad to their purposes.
Organisational factors
Teams with a lower starting level had more room for
improvements. For example, only teams with no structured COPD
care developed new protocols. Furthermore, four teams changed
smoking cessation support because most teams reported that this
was already integrated in their COPD care. Moreover, four teams
did not re-allocate tasks from the GP to the practice nurse because
they reported that most of the COPD care had already been
re-allocated to the practice nurse.
The implementation was also facilitated by the feedback reports
on the health outcomes of their patients that each practice
received. Several teams indicated a better overview and greater
ability to manage progression of their COPD patients. In this way,
the reports helped to actively track high-risk COPD patients.
Four teams reported changes in referring patients to primary/
secondary care. Three teams explicitly discussed referral criteria,
whereas in one team the lung specialist noticed changes in
primary care and referred more patients back without explicit
deliberation. A barrier for task re-allocation from secondary to
primary care was that not every lung specialist adhered to the new
agreements.
The main barrier to improving cooperation with the dietitian
was the low proportion of patients who were eligible to be
referred for nutritional support. The low number of patients and
staff turnover was also reported as reasons for not using
Zorgdraad and organising periodically scheduled multidisciplinary
meetings. In addition, problems with transferring information to
the team’s information system was an important barrier in
Zorgdraad.
Broader societal factors
A bundled payment scheme for COPD patients was introduced in
the Netherlands, almost simultaneously with the start of
RECODE.13 Since this reform, health insurers purchase integrated
multidisciplinary COPD care from care groups. As a result, the
focus on COPD care increased, ﬁnancial coverage improved, and/
or secondary caregivers became more involved. This facilitated the
implementation of RECODE. However, three teams reported that
they abandoned or temporarily stopped RECODE because they
had to concentrate on preparing the integrated care programme
as was purchased by the insurer and the formal installation of a
Table 1. Sample characteristics
Characteristics of the primary-care teams (N=20)
Practice location, urban, n (%) 14 (70)
Practice type, single-handed practice, n (%) 8 (40)
Practice type, one or more partner practice, n (%) 9 (45)
Practice type, healthcare centre, n (%) 3 (15)
Patient practice population, n (range) 3,900
(1,900–8,100)
Participating COPD patients, (range) 28 (11–55)
Ethnic minorities, % 16 (1–60)
Years practising GP, y 13 (3–25)
Starting levela
Ad hoc reactive COPD care, n (%) 9 (53)
Structural diagnosis of COPD patients, n (%) 4 (24)
Structural diagnosis and proactive follow-up of
COPD patients, n (%)
4 (24)
Patient characteristics (N= 554)
Men, % 50.5
Age (mean, s.d.) 68.2 (11.3)
GOLD stage I, % 25.3
GOLD stage II, % 52.6
GOLD stage III, % 19.0
GOLD stage IV, % 3.1
CCQ (mean, s.d.) 1.54 (0.98)
SGRQ (mean, s.d.) 36.7 (21.1)
EQ-5D (mean, s.d.) 0.74 (0.25)
MRC (mean, s.d.) 2.06 (1.30)
MET minutes (mean, s.d.) 3,101 (4,652)
SMAS, taking initiatives (mean, s.d.) 56.8 (18.1)
SMAS, investment behaviour (mean, s.d.) 61.4 (17.0)
SMAS, self-efﬁcacy (mean, s.d.) 66.0 (17.2)
Abbreviations: CCQ, Clinical COPD Questionnaire; EQ-5D, EuroQoL-5D;
MET, metabolic equivalent time; MRC, Medical Research Council; SGRQ,
St George’s Respiratory Questionnaire; SMAS, Self-Management
Ability Scale.
aStarting level was missing in three teams.
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Table 2. Implementation of 19 interventions of integrated COPD care over a 2-year follow-up period per primary-care team
Interventions Teams Total
I II III IV V VI VII VIII IX X XI XII XIII XIV XV XVI XVII
Delivery system design
Improved cooperation with physiotherapist(s) 0 0 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 15
Improved cooperation with dietician(s) 0 0 0 0 1 1 0 1 1 1 1 0 1 1 1 1 0 10
Improved cooperation with lung specialist(s) 0 0 0 0 0 0 1 0 0 0 0 0 0 1 0 1 0 3
More multidisciplinary PCT meetings 0 0 1 0 0 0 0 0 0 1 0 0 0 1 0 1 1 5
Task re-allocation from GP to practice nurse or specialised nurse 0 1 0 1 0 0 0 1 0 0 0 1 0 0 1 1 1 7
Substitution of care from secondary to primary care 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 1 1 4
Change in follow-up and visit structure 0 0 0 0 1 0 0 1 0 0 1 1 1 1 1 1 1 9
Decision support
Attendance of four disciplines at the initial RECODE course 0 0 1 0 0 0 1 1 0 1 1 1 0 1 0 1 1 9
Attendance of two or more disciplines at the RECODE refresher day(s) 1 0 0 0 0 1 0 0 1 0 0 1 0 1 1 1 1 8
Implementation/amending COPD protocol 0 0 0 0 0 0 0 0 0 0 1 0 1 1 1 1 1 6
More use of results from quality-of-life and COPD symptom
questionnaires as part of consultation
0 1 0 0 1 1 0 0 1 1 1 1 1 0 1 1 1 11
Self-management strategies
More individual treatment plans are developed 0 0 0 0 0 0 1 0 1 1 1 1 1 1 1 0 1 9
Change in smoking cessation support 0 1 0 0 0 0 0 0 1 0 0 0 1 1 0 0 0 4
Early recognition of exacerbations 0 0 1 1 1 0 1 1 1 1 1 1 1 0 1 1 1 13
Change in motivational interviewing 0 1 0 0 0 0 1 0 0 0 0 0 1 0 0 0 0 3
Clinical information system
Initial use of the ICT support system Zorgdraad 0 0 0 0 0 1 1 0 1 1 0 1 0 1 0 1 1 8
Sustained use of the ICT support system Zorgdraad 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Change in active identiﬁcation and monitoring of high-risk COPD
patients inside the practice, for example, using feedback reports
1 0 0 1 1 1 0 1 0 1 1 1 1 1 1 0 1 12
Healthcare system
Additional funding for physiotherapy 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 1 2
Total implementation score 2 4 4 4 6 6 7 7 8 9 9 10 11 12 12 13 14
Starting level 3 1 3 1 3 1 2 2 2 3 1 1 2 1 1 1 1
Abbreviations: COPD, chronic obstructive pulmonary disease; GP, general practitioner; ICT, information and communication technology; PCT,
primary-care team.
Table 3. Level of integrated care experienced by the patients (PACIC) and healthcare provider (ACIC)




Mean s.d. Mean s.d. Mean s.d. Mean s.d. Mean s.d.
PACIC (N= 436 (baseline), N= 457 (12 months), N= 353 (24 months))
Patient activation 2.31 1.26 2.29 1.14 2.33 1.16 − 0.03 1.34 − 0.08 1.34
Decision support 2.91 1.15 2.73 1.13 2.75 1.11 − 0.19** 1.17 − 0.25** 1.14
Goal setting 2.12 1.01 2.16 0.98 2.17 0.97 0.05 1.05 − 0.05 1.03
Problem solving 2.22 1.15 2.26 1.13 2.27 1.15 0.04 1.18 − 0.06 1.17
Follow-up 1.83 0.9 1.93 0.93 1.99 0.96 0.12* 0.98 0.08 0.96
Total PACIC score 2.28 0.95 2.26 0.94 2.31 0.96 − 0.05 0.95 − 0.05 0.95
ACIC (N= 20 (baseline), N= 13 (12 months))
Organisation of healthcare system 5.49 2.57 6.63 1.67 — — 1.32* 2.07 — —
Community linkages 4.94 2.25 5.89 2.07 — — 1.23* 1.53 — —
Self-management 5.09 1.65 6.37 1.55 — — 1.55* 1.87 — —
Decision support 6.12 1.81 6.59 0.93 — — 0.47 1.7 — —
Delivery system design 6.24 1.96 6.32 1.54 — — 0.32 2.06 — —
Clinical information system 5.31 2.18 5.68 1.19 — — − 0.04 1.98 — —
Integration score 4.61 1.79 4.97 1.38 — — 0.45 2.18 — —
Total ACIC score 5.41 1.73 6.07 1.10 — — 0.75 1.44 — —
Abbreviations: ACIC, Assessment Chronic Illness Care; PACIC, Patient Assessment Chronic Illness Care.
*Po0.05 **Po0.01.
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care group. A care group is a legal entity, usually owned by GPs,
which subcontracts individual professionals to provide care.
The lack of full reimbursement of physiotherapy and smoking
cessation support was an important barrier to patient participation
in these RECODE components. The lack of reimbursement of
physiotherapy was partly solved by the RECODE research team,
which arranged supplementary funding by healthcare insurers for
COPD-speciﬁc exercise training programmes for patients with an
MRC (Medical Research Council) dyspnoea score 42, including
those without supplementary health insurance. The reason for the
limited use (12%) of the funding remains unclear. One respondent
stated that the funding was not used because attention to
RECODE declined, and many patients did not qualify for the
reimbursement.
Association between level of implementation and health
outcomes
Table 5 shows the association between the level of implementa-
tion of RECODE (as measured either by our own implementation
scale, by the change in PACIC or the change in ACIC) and the
change in health outcomes within the same time period. A higher
level of integrated care as measured by the self-developed scale
was not associated with better health outcomes (Table 5). The
indirect assessment of implementation, measured as the change
in the level of integrated care from the patient’s perspective
(PACIC), was associated with a signiﬁcantly higher ‘SMAS (Self-
Management Ability Scale), taking initiatives’ score and a
signiﬁcantly higher ‘SMAS, investment behaviour’ score. For
example, one unit improvement in PACIC score between baseline
and 24 months was associated with a 1.2 unit improvement in
‘SMAS taking initiative score’ between baseline and 24 months.
This association was not found in other health outcomes. Over the
1-year study period, the total score on changed level of integrated
care from the healthcare provider’s perspective (ACIC) was not
associated with better health outcomes. Within the subgroup of
patients with a clinically relevant improvement on the CCQ
(Clinical COPD Questionnaire) or SGRQ (St George Respiratory
Questionnaire), a higher level of integrated care (self-developed
scale, PACIC or ACIC) was not associated with better health
outcomes.
Table 4. The encountered barriers and facilitators of the multidisciplinary teams to their implementation of the RECODE programme
Facilitators Barriers
Individual factors
Improved knowledge of healthcare providers Unmotivated patients for changing lifestyle because of underestimation of
COPD symptoms
Motivated healthcare providers to change COPD care Unmotivated healthcare providers for using ‘Zorgdraad’ because of unclear
instructions, the inconvenient system and a lack of time to determine how
‘Zorgdraad’ works
Social factors
The implementation experiences of the teams motivated and
inspired other teams
Variability in adoption of ‘Zorgdraad’ between team members jeopardised
the potential contribution of the ICT system to their purposes
Organisational factors
Low starting level of integrated care results in room for
improvements
Lack of adherence to the agreements between primary and secondary care
The practice-tailored feedback reports on patients’ health
outcomes develop insight into own routines and patient needs
Small proportion of COPD patients who are in need of multidisciplinary
treatment
Staff turnover who followed the RECODE course(s)
Problems with transferring information from ZORGDRAAD onto the
different clinical information systems the practices used
Broader societal factors
Better guidance and/or ﬁnancial arrangements arranged by the
care group to improve COPD care
Lack of reimbursement of exercise programmes and nutritional support
Reimbursement of smoking cessation counselling and medication
conditional on certain factors; when provided by healthcare providers who
are registered as smoking cessation counsellors
Abbreviations: COPD, chronic obstructive pulmonary disease; ICT, information and communication technology.





Δ PACICb Δ ACICa
β N β N β N
Δ CCQ 0.001 327 − 0.021 1629 0.004 297
Δ SGRQ − 0.138 308 − 0.119 1624 0.492 284
Δ EQ-5D 0.004 330 − 0.001 1701 − 0.016 280
Δ MRC 0.074 345 − 0.037 1733 − 0.02 287
Δ MET minutes 94 310 173 1710 390 250
Δ SMAS, taking
initiatives
0.01 309 1,211** 1719 1.004 251
Δ SMAS, investment
behaviour
− 0.228 310 1,349** 1712 0.781 252
Δ SMAS, self-efﬁcacy −0.013 308 0.592 1708 0.443 252
Abbreviations: ACIC, Assessment Chronic Illness Care; CCQ, Clinical COPD
Questionnaire; EQ-5D, EuroQoL-5D; MET, metabolic equivalent time; MRC,
Medical Research Council; PACIC, Patient Assessment Chronic Illness Care;
SGRQ, St George’s Respiratory Questionnaire; SMAS, Self-Management
Ability Scale.
*Po0.05, **Po0.01.
aTwo-level models (patients nested in teams), correcting for starting score
of different health outcomes and starting level of COPD care.
bThree-level models (measurement occasions nested in patients nested in
teams), correcting for time, starting score of different health outcomes and
level of COPD care.
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DISCUSSION
Main ﬁndings
This study showed that a pragmatic (non-experimental) imple-
mentation of a COPD-DM programme resulted in a low level and a
wide variety of implementation across different teams. Important
barriers to implementation were insufﬁcient motivation of
patients, high starting level of COPD care, small size of the COPD
population per team, mild COPD population, practicalities of the
ICT system, and hurdles in the reimbursement. Level of
implementation as measured with our own scale and the ACIC
was not associated with health outcomes. A higher level of
implementation measured with the PACIC was positively asso-
ciated with improved self-management capabilities, but this
association was not found for other outcomes.
Interpretation of ﬁndings in relation to previously published work
In line with previous pragmatic studies,14,15 the teams implemen-
ted various interventions, but none implemented all interventions.
Indeed, on average, less than half (42%) of the interventions were
implemented despite the fact that the individual interventions
have been shown to improve health outcomes.1,5,16,17 These
ﬁndings further support the idea of Pinnock et al18 who suggest
that after proven efﬁcacy the translation of interventions into a
practical service should be evaluated in an implementation study.
This translation seems to result in lower but more realistic
outcomes of the interventions.19,20
RECODE was facilitated by informed and motivated caregivers,
which corroborates an earlier study.10 Despite this, the caregivers
were not able to implement all the interventions. In addition, they
became demotivated because Zorgdraad was not adequately
functioning on time.
COPD patients were not always motivated to change; as COPD
patients perceive their suboptimal health status as ‘normal’, COPD
had become a way of life.21 Excluding unmotivated patients may
improve the (cost-)effectiveness of COPD-DM programmes.
Speciﬁc interventions to change the motivational status of
patients are therefore required.
A barrier for implementation was the low potential for
improvement owing to the high starting level of COPD care and
the mild COPD population. The absence of improvements owing
to already high levels of COPD care was pointed out in earlier
primary-care trials.22,23
The perceived usefulness of Zorgdraad was low. The teams that
did use Zorgdraad experienced problems with practicalities and
variability in adoption of the system between team members.
Furthermore, teams reported unclear instructions and a lack of
time or motivation to determine how Zorgdraad worked. A large
review corroborates that usefulness, compatibility with work and
time were important barriers for the implementation of an ICT
system.24
The last important barrier to implementation was the hurdle in
reimbursement. As teams reported the formation of care groups
as facilitators, the ongoing wide implementation of the bundled
payment system in the Netherlands might be a positive step
towards solving the reimbursement issue. In this system,
healthcare insurers purchase integrated multidisciplinary COPD
care from care groups.25 However, in practice, the ﬁnanced
package varies widely, and therefore not all multidisciplinary care
required by a COPD patient is included.26
In accordance with our results, previous studies have demon-
strated that an improved PACIC score improved self-
management.14,27 Despite this, our self-developed scale or ACIC
score was not associated with better health outcomes. Therefore,
implementation of only a few interventions by some teams does
not guarantee improvements in patient outcomes in comparison
with other teams.
Strengths and limitations of this study
This study has several strengths. First, a broad range of outcome
measures and implementation measurements including different
perspectives were used. Second, independent scoring of the
self-developed scale ensured the objectivity of the results. Third,
the interviewer was not involved in the core research team, which
reduced the pressure to give desirable answers.
To empower and prepare paents to 
manage their disease  
Healthcare providers were trained to 
support self-management by 
developing and applying individual 
treatment plans, using movaonal 
interviewing to support smoking 
cessaon, physical acvity and early 
recognion of exacerbaons.   
Assures the delivery of eﬀecve and eﬃcient 
clinical and behavioural care 
The RECODE program smulated cooperaon of 
the GP and pracce nurse with the 
physiotherapist(s), diecian(s) and lung 
specialist(s). Therefore, muldisciplinary team 
meengs could be scheduled and task re-
allocaon from secondary to primary care and 
from GP to pracce nurse could be implemented. 
Furthermore, the team could change frequency 
and structure of inial ánd follow-up visits 
To assure access to mely, relevant 
data about paents  
The pracces had access to the ICT 
support system Zorgdraad. This 
applicaon combined a paent and a 
healthcare provider portal, and 
facilitated pracce-tailored feedback 
reports. 
To consider the policy and ﬁnancing context
The pracces could apply for funding for exercise 
programmes, also for paents without supplemental
health insurance. 
Promote the use of evidence-based clinical care 
The healthcare providers were trained to provide 
care according to the Dutch COPD guidelines at 
the RECODE course and the refresher courses. 
During these courses, the pracces received an 
example of a COPD protocol. Furthermore, the 
healthcare providers were trained in the 
interpretaon and using of quality-of-life and 
COPD symptom quesonnaires as part of the 
consultaon. 
To link community and healthcare delivery
There were no speciﬁc intervenons aimed at 
improving this CCM element. 
Figure 1. The RECODE interventions grouped by the components of the Chronic Care Model (CCM) from Wagner et al.30 COPD, chronic
obstructive pulmonary disease; GP, general practitioner; ICT, information and communication technology.
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This study also has several weaknesses. It was not possible to
compare the implemented interventions of the intervention teams
with the control teams because, to prevent an additional
intervention effect, we did not evaluate changes in COPD care
in the control group. Therefore, it was not always possible to
determine whether changes were caused by RECODE or other
factors, such as parallel projects. Second, most interviews were
held with only one representative of the team. However, we
interviewed practice nurses or GPs, who were the project leaders
and provided the best overview of COPD care in their team. Third,
the response rate on the ACIC questionnaire at 12 months was low
(65%). However, the ACIC score at baseline did not differ much
between the responders and the non-responders.
Implications for future research, policy and practice
This study showed that a pragmatic COPD-DM programme that
primarily targets caregivers seems to result in only modest
improvements in care. We learnt that focus should be more on
patient-oriented interventions. Hence, multiple COPD-DM
programmes have shown that patient-oriented interventions or
a combination of patient-oriented, provider-oriented and
organisational interventions lead to signiﬁcant improvements in
health outcomes.14,28 Furthermore, the interventions should be
tailored to patients’ needs, skills and preferences, which will imply
that, on average, a COPD-DM programme for milder COPD
patients will include fewer or less-intensive interventions than a
COPD-DM programme for more severe patients.
The room for improvement and the proportion of motivated
patients is higher among a selection of COPD patients with a high
disease burden. However, focussing on more severe COPD
reduces the number of patients who participate in the pro-
gramme. Consequently, the motivation of professionals to invest
time in optimising the programme and negotiating with health
insurers on reimbursement of the programme may decrease. It is a
challenge for further programmes to ﬁnd the right balance
between sufﬁcient room for improvement and economies of scale.
In ﬁnding this balance, we should account for the fact that
long-term gains can be increased if we can prevent moderate
COPD patients from progressing to severe COPD.
Conclusions
This study adds valuable input to the discussion on development
and implementation of COPD-DM programmes. We observed a
low level and wide variability of implementation across different
primary-care teams. Barriers and facilitators of the implementation
were related to factors at individual, social, organisational and
broader societal level. There was little association between the
level of implementation and improved health outcomes.
MATERIALS AND METHODS
Intervention
RECODE is a two-year cluster-RCT in which 40 primary-care teams were
randomised to DM or usual care.12 The 20 intervention teams received a
2-day training course in essential elements of effective COPD-DM. These
elements are grouped by components of the Chronic Care Model (CCM),
and described in Figure 1. The CCM is often used as conceptual framework
for development and evaluation of DM programmes.1,5,16,29 The core of the
CCM is the productive interaction between informed, activated patients
and prepared, proactive teams of caregivers.30 RECODE included interven-
tions to improve ﬁve of the six interrelated CCM components. After the
course, the teams were invited to join two refresher courses and had
access to the ICT system ‘Zorgdraad’. All the teams were encouraged to
write their own reform plan and tailor implementation strategies to their
local circumstances. Therefore, the package of interventions that patients
received was not only dependent upon their health status, personal needs
and preferences but also on local adaptation and level of implementation
of interventions.
The ICT system ‘Zorgdraad’ included a patient portal and a healthcare
provider portal, but was not an e-consultation system. The patient portal
contained educational material and had a section containing personal
treatment goals and room to write down personal notes. The provider
portal had room for a protocol to guide frequency and content of COPD
monitoring, entering quality-of-life scores and results from follow-up and
examinations. Information from Zorgdraad was used to generate
practice-tailored feedback reports on patients’ health outcomes at baseline
and at 6 and 12 months. These reports were generated by the researchers
and sent to the practices to support prioritising the healthcare needs. It
was intended that practice nurses would give the COPD patients
instructions and information through the patient portal.
Participants
The 20 intervention teams included at least one GP, one practice nurse and
one physiotherapist specialised in COPD care. Thirteen teams also included
a dietitian. The teams enrolled 554 COPD patients according to the Global
Initiative for COPD (GOLD) guidelines,31 and because few exclusion criteria
were applied, they represent the primary-care COPD population in the
Netherlands.12
Setting
In the Netherlands, GPs act as gatekeepers to hospital care; patients need a
referral from the GP to visit a specialist in a hospital clinic.32 Hence, the vast
majority of COPD patients are treated by the GP. The Ministry of Health
activity has been stimulating the implementation of integrated care
programmes for chronic diseases such as COPD for quite some time. This
was reinforced by the introduction of a bundled payment system in
2010.13 This has strengthened the collaboration between different
primary-care professionals involved in COPD care. Primary-care practice
nurses have a key role in providing integrated care. A practice nurse is a
new profession that was introduced in the early 2000s, and several tasks
formerly performed by GPs were shifted towards this nurse.32 The majority
(80%) of the practice nurses have a general background in nursing and
receive additional training in one or more chronic diseases. They are
predominantly involved in the care of chronically ill patients. For COPD
patients this includes, for example, periodic monitoring, spirometry testing,
inhalation instructions, smoking cessation counselling, coaching patients
to become more physically active, and teaching patients to recognise
exacerbations early.33 At present, 80% of the Dutch practices, which have
an average practice size of 2,350 patients, have at least one practice nurse
who takes care of chronically ill patients for at least 2 days a week.
Implementation
The level of implementation was measured directly with a self-developed
scale. The scale measured the implementation of 19 interventions in ﬁve
CCM components that were included in the RECODE programme
(Appendix 1). Three researchers independently assessed whether an
intervention was actually implemented (score= 1) or not (score=0), and
disagreements were discussed in a consensus meeting. The sum of these 19
scores comprised the total score on the self-developed scale. The
information that the researchers used to score the scale was obtained from
a questionnaire administered to the teams after 1 year and a semi-
structured telephone interview with the teams after 2 years. Questions were
asked about COPD care before RECODE, changes in COPD care as a result of
RECODE, and barriers to and facilitators of implementation. The interviews
were recorded and transcribed verbatim. Finally, information was recorded
on attendance of professionals at the training and refresher courses, as well
as on ICT use and use of additional reimbursement for physiotherapy.
The level of implementation was also measured indirectly through the
assessment of the level of integrated care that was achieved. The latter was
measured from the patient’s perspective with the PACIC Questionnaire34 at
baseline and at 6, 9, 12, 18 and 24 months (ranging from 1 (lowest level) to
5 (highest level)) and from the healthcare provider’s perspective using the
ACIC (ranging from 0 to 11, with 11 representing optimal care) at baseline
and at 12 months.35
Barriers and facilitators
Reported barriers and facilitators of implementation were categorised as
individual, social, organisational or broader societal factors.36 Individual
factors were related to caregivers and consisted of cognitive, motivational
and behavioural factors, as well as personal characteristics including health
Variation in implementation of the RECODE trial
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status. Social factors were related to professional teams/networks.
Organisational factors included the organisational structure, culture and
work processes, as well as the availability of necessary resources. Societal
factors related to the healthcare system and to societal and political
developments.
Starting level
We distinguished three starting levels: (i) ad hoc reactive COPD care; (ii)
structural diagnosis of COPD patients; and (iii) structural diagnosis and
proactive follow-up of COPD patients. Teams with ‘ad hoc reactive COPD
care’ had (virtually) no DM. For these teams, RECODE marked the start of
structured COPD care. Teams with ‘structural diagnosis of COPD patients’
had begun to structure their COPD care, performed spirometry and had an
overview of the COPD population in their practice. Teams with ‘structural
diagnosis and proactive follow-up of COPD patients’ additionally had an
established control-visit/follow-up structure, and applied strategies to
support self-management.
Health outcomes
We measured health-related quality of life on the CCQ,37 SGRQ38 and the
EQ-5D.39,40 We measured dyspnoea by means of the MRC dyspnoea score
with a scale from 1 to 5,41 physical activity by means of the International
Physical Activity Questionnaire42 and self-management abilities by means
of the components ‘taking initiatives’, ‘investment behaviour’ and ‘level of
self-efﬁcacy’ from the Self-Management Ability Scale-30.43 The question-
naires were administered at baseline and at 6, 9, 12, 18 and 24 months.
Statistical analysis
Descriptive statistics of patients’ and teams’ characteristics were
calculated. We used two-tailed, paired t-tests to investigate
improvements in the level of integrated care as measured by the PACIC
and the ACIC.
During the RECODE study, there was a variation in changed outcomes
in the intervention group.44 In this study, we investigated the
association between variation in implementation as measured with
our own developed scale and ACIC and change in health outcomes
within the same time period using two-level (patients nested in teams)
linear mixed-effect models, correcting for starting score of different
health outcomes and starting level of COPD care. To investigate the
impact of the level of implementation as measured with the PACIC on
change in health outcomes within the same time period, we used
three-level (longitudinal measurements nested in patients nested in
primary-care teams) linear mixed-effect models, correcting for time,
starting score of different health outcomes and starting level of COPD
care. We used six time points (baseline, 6, 9, 12, 18 and 24 months) to
estimate the impact of implementation as measured with the PACIC. These
models were speciﬁed for eight dependent variables: change in CCQ,
SGRQ, EQ-5D, MRC, MET minutes, taking initiatives, investment behaviour
and self-efﬁcacy.
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APPENDIX
Appendix 1. Detailed description of the different interventions
and results of the RECODE programme




The practice nurse, GP and
physiotherapist(s) have agreed on the
indications of referral, communication
regarding patients and coordination
of the
treatment of COPD patients.
Improved cooperation with
dietician(s)
The practice nurse, GP and dietician(s)
have agreed on the indications of
referral, communication regarding
patients and coordination of the
treatment of COPD patients.
Improved cooperation with lung
specialist(s)
The practice nurse, GP and lung
specialist(s) have agreed on the
indications of referral, communication
regarding patients and coordination




individual COPD patients, exchanging
medical knowledge, and/or
organisation of care with at least the
GP, practice nurse and
physiotherapists
Task re-allocation from GP to
practice nurse or specialised nurse
The practice nurse has taken over
tasks that were tasks of the GP before
the start of the RECODE study.
Substitution of care from secondary
to primary care
Primary healthcare providers have
taken over tasks that were tasks of
secondary healthcare providers
before the start of the RECODE study.
Change in follow-up and visit
structure
Patients visit the practice nurse or
GP according to a structural follow-up
plan.
Appendix 1. (Continued )
Intervention Explanation of result
Decision support
Attendance of four disciplines at
the initial RECODE course
Four different disciplines of healthcare
providers (GP, practice nurse,
physiotherapist, dietician) of the team
attended the RECODE course.
Attendance of two or more
disciplines at the RECODE refresher
day(s)
Two or more healthcare providers
from different disciplines attended
the reunion.
Implementation / amending COPD
protocol
The original COPD protocol is adapted
or a new COPD protocol is developed
and implemented.
More use of results from quality-of-
life and COPD symptom
questionnaires as part of
consultation
The practice nurse started to use
quality-of-life questionnaires (e.g.,
Clinical COPD Questionnaire (CCQ) or
MRC) in consultation with patients
Self-management strategies
More individual treatment plans are
developed
Patients and practice nurses or GPs
began to jointly formulate personal
goals and these goals are recorded in
the patient’s ﬁle.
Change in smoking cessation
support
The practice nurse or GP pays
different/more attention to smoking
cessation than before the start of the
RECODE study.
Early recognition of exacerbations The practice nurse or GP pays more
attention to teaching patients the
early recognition of and the way to
respond to exacerbations than before
the start of the RECODE study.
Change in motivational
interviewing
The practice nurse or GP started to
use the motivational interviewing
technique (more often) to understand
and make use of patients’ personal
goals in physical reactivation and
lifestyle changes.
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Appendix 1. (Continued )
Intervention Explanation of result
Clinical information system
Initial use of the ICT support system
Zorgdraad
The healthcare provider(s) actively
tried to use Zorgdraad by logging into
Zorgdraad and receiving individual
instructions from an ICT
implementation expert.
Sustained use of the ICT support
system Zorgdraad
Using Zorgdraad after 12 months
Change in active identiﬁcation and
monitoring of high-risk COPD
patients inside the practice, for
example, using feedback reports
Active identiﬁcation and monitoring
of high-risk patients inside the
practice




The practice used the supplementary
funding provided by the local
healthcare insurer for a COPD-speciﬁc
exercise training programme for
RECODE patients with MRC scores
42.
Abbreviations: CCQ, Clinical COPD Questionnaire; COPD, chronic
obstructive pulmonary disease; GP, general practitioner; ICT, information
and communication technology; MRC, Medical Research Council.
Appendix 2. Response rate







PACIC 436 (79) 457 (82) 353 (64)
CCQ 553 (100) 515 (93) 394 (71)
SGRQ 550 (99) 496 (90) 372 (67)
EQ-5D 546 (99) 498 (90) 408 (74)
MRC 553 (100) 499 (90) 418 (75)
MET minutes 515 (93) 472 (85) 395 (71)
SMAS, taking initiatives 518 (94) 476 (86) 391 (71)
SMAS, investment
behaviour
517 (93) 475 (86) 391 (71)
SMAS, self-efﬁcacy 516 (93) 473 (85) 391 (71)
Healthcare provider
12-month questionnaire — 13 (65) —
ACIC 20 (100) 13 (65) —
Abbreviations: ACIC, Assessment Chronic Illness Care; CCQ, Clinical COPD
Questionnaire; EQ-5D, EuroQoL-5D; MET, metabolic equivalent time; MRC,
Medical Research Council; PACIC, Patient Assessment Chronic Illness Care;
SGRQ, St George’s Respiratory Questionnaire; SMAS, Self-Management
Ability Scale.
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